<p>(<b>a</b>) The Hela cells were transfected with 2 µg of each plasmid encoding B Vpr, C Vpr and Vpr variants and cells were harvested after 24 hrs using Trypsin EDTA. Cells were then washed with PBS, fixed in 70 percent ethanol, treated with RNase A and stained with PI. After staining, cells were analyzed in PI/RNase solution by flow cytometry. Apoptotic cells were observed as a separate peak before G1 phase. Percentage apoptosis recorded with each variant is shown at the upper right corner. B/C/D recombinants Vpr 45 and Vpr 46 induce less apoptosis then wild type Vpr. Results shown here are the representatives of three independent experiments. <b>b</b>) The percentage of apoptotic cells for each sample was plotted as a bar diagram compar...
(A) Apoptosis analysis in HT-29 cells. (B) Apoptosis analysis in ZR-75-1 cells. In both cases, the g...
<p>Cell apoptosis in each group were detected using an RNA interference technique and AV/PI staining...
<p>(A) PBMCs were treated with or without 5 µM Vpr peptide (amino acids 52–96) and increasing concen...
<div><p>(A) HeLa cells were transduced with pHR-VPR-G or mock-transduced and then incubated with 2 m...
<p>(<b>a</b>) Hela cells were transfected with 2 µg of each plasmid encoding B Vpr, C Vpr and Vpr va...
<p><b>A.</b> Vpr induces dose-dependent cell death in drug-naïve and resistant SK-N-SH cells. <b>a.<...
<p>HeLa cells were co-transfected with plasmids for expression of GFP and HA-Vpr in combination with...
<p>(A) Apoptotic cells expressing wild-type GPR37-myc, GPR37(R558Q)-myc or GPR37(Del312F)-myc. Green...
<p>(A) Schema illustrating the cell cycle alteration(s) observed in HeLa/Fucci2 cells. HeLa/Fucci2 c...
<div><p>(A) Thymidine-synchronized HeLa cells transduced with pHR-VPR-G or mock-transduced were rele...
<p>Splenic MNCs of WT HIV-1-infected mice (n = 7), <i>vpr</i>-deficient HIV-1-infected mice (n = 7),...
<p>(<b>A</b>) WT or mutant Vpr proteins (denoted by the single letter amino acid changes) were deliv...
<p>(A and B) Immunofluorescence analysis of apoptosis in PAMs and Marc-145 cells. Apoptosis (green),...
<p>The different stages of cell cycle and the percentage of cells with subG<sub>0</sub> DNA content ...
<p>HPB-ALL T lymphoid cells were co-transfected with vectors for expression of HA tagged Vpr<i>Lai</...
(A) Apoptosis analysis in HT-29 cells. (B) Apoptosis analysis in ZR-75-1 cells. In both cases, the g...
<p>Cell apoptosis in each group were detected using an RNA interference technique and AV/PI staining...
<p>(A) PBMCs were treated with or without 5 µM Vpr peptide (amino acids 52–96) and increasing concen...
<div><p>(A) HeLa cells were transduced with pHR-VPR-G or mock-transduced and then incubated with 2 m...
<p>(<b>a</b>) Hela cells were transfected with 2 µg of each plasmid encoding B Vpr, C Vpr and Vpr va...
<p><b>A.</b> Vpr induces dose-dependent cell death in drug-naïve and resistant SK-N-SH cells. <b>a.<...
<p>HeLa cells were co-transfected with plasmids for expression of GFP and HA-Vpr in combination with...
<p>(A) Apoptotic cells expressing wild-type GPR37-myc, GPR37(R558Q)-myc or GPR37(Del312F)-myc. Green...
<p>(A) Schema illustrating the cell cycle alteration(s) observed in HeLa/Fucci2 cells. HeLa/Fucci2 c...
<div><p>(A) Thymidine-synchronized HeLa cells transduced with pHR-VPR-G or mock-transduced were rele...
<p>Splenic MNCs of WT HIV-1-infected mice (n = 7), <i>vpr</i>-deficient HIV-1-infected mice (n = 7),...
<p>(<b>A</b>) WT or mutant Vpr proteins (denoted by the single letter amino acid changes) were deliv...
<p>(A and B) Immunofluorescence analysis of apoptosis in PAMs and Marc-145 cells. Apoptosis (green),...
<p>The different stages of cell cycle and the percentage of cells with subG<sub>0</sub> DNA content ...
<p>HPB-ALL T lymphoid cells were co-transfected with vectors for expression of HA tagged Vpr<i>Lai</...
(A) Apoptosis analysis in HT-29 cells. (B) Apoptosis analysis in ZR-75-1 cells. In both cases, the g...
<p>Cell apoptosis in each group were detected using an RNA interference technique and AV/PI staining...
<p>(A) PBMCs were treated with or without 5 µM Vpr peptide (amino acids 52–96) and increasing concen...